¼¼°èÀÇ 4D ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ ½ÃÀå º¸°í¼­(2025³â)
4D Bioprinting Global Market Report 2025
»óǰÄÚµå : 1680797
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,342,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,167,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,992,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

4D ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ºñ¾àÀûÀÎ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â¿¡´Â 29.9%ÀÇ CAGR·Î 3,400¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº Àå±â ÀÌ½Ä ¼ö¿ä Áõ°¡, °í·ÉÈ­ Àα¸ Áõ°¡, ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, ÀÇ·á ÁöÃâ Áõ°¡, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü, »êÇÐÇù·Â, ÀΰøÁö´ÉÀÇ ÅëÇÕ, ºÐ»êÇü Á¦Á¶·ÎÀÇ Àüȯ, 3D À̹Ì¡ ±â¼ú°úÀÇ ÅëÇÕ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

Àå±â À̽Ŀ¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È 4D ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àå±â À̽ÄÀº Àå±â ºÎÀüÀ̳ª ±â´É Àå¾Ö·Î ÀÎÇØ Àå±â³ª Á¶Á÷ÀÌ ÇÊ¿äÇÑ °³ÀÎ(±âÁõÀÚ)¿¡¼­ ´Ù¸¥ °³ÀÎ(¼öÇýÀÚ)¿¡°Ô ¿Ü°úÀûÀ¸·Î À̽ÄÇÏ´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä´Â Àå±â ºÎÀüÀ̳ª ±â´É Àå¾Ö¸¦ ¾Î°í ÀÖ´Â »ç¶÷µéÀÇ »ý¸íÀ» ±¸ÇÏ°í »îÀÇ ÁúÀ» Çâ»ó½ÃÄÑ¾ß ÇÑ´Ù´Â ¸Å¿ì Áß¿äÇÑ Çʿ伺¿¡¼­ ºñ·ÔµÈ °ÍÀ¸·Î, 4D ¹ÙÀÌ¿ÀÇÁ¸°ÆÃÀº Àç»ýÀÇÇÐÀ» ¹ßÀü½ÃÄÑ Àå±â À̽ÄÀ» Áö¿øÇϰí, ±â´ÉÀû ´É·ÂÀ» °®Ãá º¹ÀâÇÑ Á¶Á÷°ú Àå±â¸¦ Á¤¹ÐÇÏ°Ô Á¦ÀÛÇÔÀ¸·Î½á ±âÁõÀÚ Àå±â ºÎÁ·¿¡ ´ëÇÑ ÀáÀçÀû ÇØ°áÃ¥À» Á¦°øÇϰí ÀÌ½Ä ¼º°ø·üÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 1¿ù ¹Ì±¹ Á¤ºÎ ±â°üÀÎ Àå±â Á¶´Þ ¹× ÀÌ½Ä ³×Æ®¿öÅ©(OPTN)ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é, 2023³â¿¡ »ýü ¹× »ç¸ÁÇÑ ±âÁõÀÚ¸¦ ÅëÇØ 46,632°ÇÀÇ Àå±â À̽ÄÀÌ ¿Ï·áµÇ¾ú½À´Ï´Ù. ÀÌ´Â 2022³â ´ëºñ 8.7%, 2021³â ´ëºñ 12.7% Áõ°¡ÇÑ ¼öÄ¡ÀÔ´Ï´Ù. ÀÌó·³ Àå±â À̽Ŀ¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ 4D ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

¸ÂÃãÇü ÀÇ·áÀÇ ºÎ»óÀ¸·Î ÀÎÇØ ÇâÈÄ ¸î ³â µ¿¾È 4D ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ ½ÃÀåÀÇ ¼ºÀåÀÌ °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸ÂÃãÇü ÀÇ·á´Â ȯÀÚ °³°³ÀÎÀÇ Æ¯¼º¿¡ µû¶ó ÀÇ·á °áÁ¤, °³ÀÔ ¹× Ä¡·á¸¦ ¸ÂÃãÈ­ÇÏ´Â ¸ÂÃãÇü ÀÇ·á Á¢±Ù ¹æ½ÄÀ» äÅÃÇϰí ÀÖÀ¸¸ç, 4D ¹ÙÀÌ¿ÀÇÁ¸°ÆÃÀº ´Ù¾çÇÑ È¯°æ Àڱؿ¡ ÀûÀÀÇÒ ¼ö ÀÖ´Â Áö´ÉÀûÀ̰í ȯ°æ ¹ÝÀÀ¼ºÀÌ ³ôÀº »ý¹°ÇÐÀû ±¸Á¶, Á¶Á÷ ¹× Àå±âÀÇ Á¦Á¶¸¦ ÃËÁøÇÔÀ¸·Î½á ¸ÂÃãÇü ÀÇ·á¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÁÖ¸ñÇÒ ¸¸ÇÑ °ÍÀº ¹Ì±¹¿¡ ±â¹ÝÀ» µÐ Àü¹® ±â°üÀÎ Personalized Medicine CoalitionÀÇ 2022³â µ¥ÀÌÅÍ¿¡ µû¸£¸é, ¸ÂÃãÇü ÀÇ·áÀÇ ½ÂÀÎÀÌ Å©°Ô Áõ°¡ÇÏ¿© Àüü ½ÂÀÎµÈ Ä¡·á¹ýÀÇ ¾à 34%¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ³ªÅ¸³µ´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÌ´Â ¸ÂÃãÇü ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ÀÌ¿¡ µû¸¥ 4D ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ ½ÃÀåÀÇ ¼ºÀå ±Ëµµ¿¡ ÈûÀ» ½Ç¾îÁÙ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

4D bioprinting represents an advanced manufacturing technique that combines 3D bioprinting with dynamic functionalities, enabling the creation of biomimetic structures capable of adapting shape or function over time in response to external stimuli. This technology facilitates the fabrication of tissues and structures that can emulate the dynamic functionalities of natural tissues.

The primary technologies utilized in 4D bioprinting include extrusion-based, laser-based, inkjet-based, and other methodologies. Extrusion-based technology involves selectively dispensing material through a nozzle or orifice to build a three-dimensional object, serving various applications including biomedical uses. These applications are employed by pharmaceutical and biotechnology companies, academic research and development institutions, among others.

The 4D bioprinting market research report is one of a series of new reports from The Business Research Company that provides 4D bioprinting market statistics, including 4D bioprinting industry global market size, regional shares, competitors with a 4D bioprinting market share, detailed 4D bioprinting market segments, market trends and opportunities, and any further data you may need to thrive in the 4D bioprinting industry. This 4D bioprinting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 4D bioprinting market size has grown exponentially in recent years. It will grow from $0.09 billion in 2024 to $0.12 billion in 2025 at a compound annual growth rate (CAGR) of 30.2%. The growth in the historic period can be attributed to rise in geriatric population, increasing healthcare expenditure, rise in 3D bioprinting startups, increasing investments in R&D, growing prevalence of chronic diseases.

The 4D bioprinting market size is expected to see exponential growth in the next few years. It will grow to $0.34 billion in 2029 at a compound annual growth rate (CAGR) of 29.9%. The growth in the forecast period can be attributed to increasing demand for organ transplant, rising aging population, increasing prevalence of chronic diseases, increasing healthcare expenditure, rising demand for personalized medicine. Major trends in the forecast period include technological advancements, collaborations between academia and industry, integration of artificial intelligence, shift towards decentralized manufacturing, integration with 3D imaging technologies.

The rising demand for organ transplants is anticipated to drive the growth of the 4D bioprinting market in the coming years. Organ transplants involve surgically transferring an organ or tissue from one individual (the donor) to another (the recipient) who requires it due to organ failure or dysfunction. This demand stems from the vital need to save lives and enhance the quality of life for those affected by organ failure or dysfunction. 4D bioprinting supports organ transplants by advancing regenerative medicine, precisely fabricating complex tissues and organs with functional capabilities, which provides a potential solution to the donor organ shortage and improves transplant success. For example, in January 2024, data from the Organ Procurement and Transplantation Network (OPTN), a U.S.-based government organization, showed that 46,632 organ transplants were completed in 2023 using both living and deceased donors. This reflects an 8.7% increase compared to 2022 and a 12.7% rise from 2021. Thus, the growing demand for organ transplants is fueling the expansion of the 4D bioprinting market.

The rising prominence of personalized medicine is anticipated to drive the expansion of the 4D bioprinting market in the forthcoming years. Personalized medicine adopts a tailored medical approach that customizes healthcare decisions, interventions, and treatments according to individual patient characteristics. 4D bioprinting assumes a critical role in personalized medicine by facilitating the fabrication of intelligent, environmentally responsive biological structures, tissues, and organs capable of adapting to diverse environmental stimuli. Notably, in 2022, data from the Personalized Medicine Coalition, a US-based professional organization, highlighted a significant increase in the approval of personalized medicines, accounting for approximately 34% of all newly approved therapies. This marks a substantial uptick from previous years, underscoring the growing demand for personalized medical solutions and subsequently driving the growth trajectory of the 4D bioprinting market.

Leading companies in the 4D bioprinting market are establishing strategic partnerships to boost their technological capabilities and speed up the development of innovative solutions in tissue engineering and regenerative medicine. These collaborations also aim to drive innovation and broaden research and development initiatives. For example, in March 2024, Poietis, a France-based biotechnology company specializing in 4D laser bioprinting, partnered with HVD Life Science. Through this partnership, Poietis seeks to promote its Next Generation Bioprinting (NGB-R) platform in Germany and enhance access to advanced bioprinting technology for researchers in tissue engineering, regenerative medicine, and drug discovery. HVD Life Science, an Austria-based company, focuses on the marketing and distribution of life science solutions.

Major companies operating in the 4D bioprinting market are 3D Systems Corporation, CELLINK AB, EnvisionTEC Inc., Advanced Solutions Life Sciences, Nanoscribe, Aspect Biosystems Ltd., Aleph Farms, BioBots Inc., Sculpteo, Prellis Biologics, Rokit Healthcare, Cyfuse Biomedical, 3D Bioprinting Solutions, 4D Biomaterials Ltd., Allevi Inc., Cellenion, FluidForm, Methuselah Health, Nanofabrica, OxSyBio Ltd., Poietis S.A.S., REGEMAT 3D S.L., Replicel Life Sciences Inc., VIVAX BIO, Organovo Holdings Inc.

North America was the largest region in the 4D bioprinting market in 2024. The regions covered in the 4d bioprinting market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the 4d bioprinting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The 4D bioprinting market consists of revenues earned by entities providing services such as consulting, design, and customization of 4D bio printed products.The market value includes the value of related goods sold by the service provider or included within the service offering. The 4D bioprinting market also includes sales of 4D bioprinters and related consumables such as bioinks and biomaterials. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

4D Bioprinting Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 4d bioprinting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for 4d bioprinting ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The 4d bioprinting market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. 4D Bioprinting Market Characteristics

3. 4D Bioprinting Market Trends And Strategies

4. 4D Bioprinting Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global 4D Bioprinting Growth Analysis And Strategic Analysis Framework

6. 4D Bioprinting Market Segmentation

7. 4D Bioprinting Market Regional And Country Analysis

8. Asia-Pacific 4D Bioprinting Market

9. China 4D Bioprinting Market

10. India 4D Bioprinting Market

11. Japan 4D Bioprinting Market

12. Australia 4D Bioprinting Market

13. Indonesia 4D Bioprinting Market

14. South Korea 4D Bioprinting Market

15. Western Europe 4D Bioprinting Market

16. UK 4D Bioprinting Market

17. Germany 4D Bioprinting Market

18. France 4D Bioprinting Market

19. Italy 4D Bioprinting Market

20. Spain 4D Bioprinting Market

21. Eastern Europe 4D Bioprinting Market

22. Russia 4D Bioprinting Market

23. North America 4D Bioprinting Market

24. USA 4D Bioprinting Market

25. Canada 4D Bioprinting Market

26. South America 4D Bioprinting Market

27. Brazil 4D Bioprinting Market

28. Middle East 4D Bioprinting Market

29. Africa 4D Bioprinting Market

30. 4D Bioprinting Market Competitive Landscape And Company Profiles

31. 4D Bioprinting Market Other Major And Innovative Companies

32. Global 4D Bioprinting Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The 4D Bioprinting Market

34. Recent Developments In The 4D Bioprinting Market

35. 4D Bioprinting Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â